{"title":"一名化疗难治性 pMMR/MSS 转移性直肠癌患者接受实验性 AlloStim® 免疫疗法后,在使用免疫检查点抑制剂后出现客观反应","authors":"Ariel Hirschfeld, Daniel Gurell, M. Har-Noy","doi":"10.1186/s41231-024-00174-y","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":75244,"journal":{"name":"Translational medicine communications","volume":"32 26","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Objective response after immune checkpoint inhibitors in a chemotherapy-refractory pMMR/MSS metastatic rectal cancer patient primed with experimental AlloStim® immunotherapy\",\"authors\":\"Ariel Hirschfeld, Daniel Gurell, M. Har-Noy\",\"doi\":\"10.1186/s41231-024-00174-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":75244,\"journal\":{\"name\":\"Translational medicine communications\",\"volume\":\"32 26\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational medicine communications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s41231-024-00174-y\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational medicine communications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s41231-024-00174-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Objective response after immune checkpoint inhibitors in a chemotherapy-refractory pMMR/MSS metastatic rectal cancer patient primed with experimental AlloStim® immunotherapy